logo

Prevail Therapeutics Inc. (PRVL)



Trade PRVL now with
  Date
  Headline
1/22/2021 8:56:32 AM Lilly Closes Acquisition Of Prevail Therapeutics; Says No Change To Lilly's 2021 Financial Guidance
12/15/2020 6:16:57 AM Amended: Eli Lilly To Acquire Prevail Therapeutics For $22.50/Shr Plus One CVR Worth Up To $4.00/Shr
12/11/2020 7:07:43 AM Prevail Therapeutics Says First Patient Dosed In Phase 1/2 PROCLAIM Clinical Trial Evaluating PR006
11/13/2020 7:18:10 AM Prevail Therapeutics Q3 Net Loss $18.6 Mln Or $0.55/Shr Vs $20.3 Mln Or $0.62/Shr Last Year
6/4/2020 7:11:43 AM Prevail Therapeutics Names Kira Schwartz General Counsel
3/24/2020 7:06:15 AM Prevail Therapeutics Secures US FDA Fast Track Designation For PR006
3/3/2020 7:17:11 AM Prevail Says Enrollment In PR001 Phase 1/2 PROPEL Clinical Trial Is Progressing